Global ETD Search

31	Dichter bij het geheim : leven en werk van Willem Barnard - Guillaume van der Graft / Troost, Andries Floris, January 1900 (has links) Proefschrift--Universiteit Utrecht, 1998. / Résumé en anglais et en allemand. Bibliogr. p. 361-384. Index.
32	Mechanisms of monocyte adhesion to human saphenous vein Crook, Martin January 2000 (has links) No description available. 572.8
33	Properties of cyclophilins and their ligands in bone Coxon, Fraser P. January 1997 (has links) No description available. 615.1 Bone metabolism; Graft rejection
34	Histology and immunopathology of skin and rectum following bone marrow transplantation Sviland, Lisbet January 1989 (has links) No description available. 610 Graft-versus-host disease
35	Quantitative analysis of alloreactive T cells in allogeneic stem cell transplantation Wang, Xiao Nong January 1997 (has links) No description available. 610 Bone marrow; Graft; Donor
36	Indirect T cell allorecognition of the RT1.A'a MHC class I molecule Lovegrove, Emma January 1999 (has links) No description available. 610
37	An investigation to determine the ability of allogeneic resting B cells to induce specific unresponsiveness in vivo Niimi, Masanori January 1998 (has links) No description available. 610 Graft rejection; Organ transplantation
38	SURGICAL MANAGEMENT OF INFECTED THORACIC ANEURYSMS Usui, Akihiko 08 1900 (has links) No description available. artificial graft infection surgery aneurysm
39	The health and well-being of individuals before and after coronary artery bypass surgery Lindsay, Grace M. January 1999 (has links) No description available. 610 CHD; Heart disease; Graft
40	Computational Optimization of Compliance Matched Tissue Engineered Vascular Grafts Harrison, Scott, Harrison, Scott January 2016 (has links) Coronary heart disease is a leading cause of death among Americans for which coronary artery bypass graft (CABG) surgery is a standard surgical treatment. The success of CABG surgery is impaired by the compliance mismatch between vascular grafts and native vessels. Tissue engineered vascular grafts (TEVGs) have the potential to be compliance matched and thereby reduce the risk of graft failure. Glutaraldehyde (GLUT) vapor-crosslinked gelatin/fibrinogen constructs were fabricated and mechanically tested in a previous study by our research group at 2, 8, and 24 hours of GLUT vapor exposure. Constructs electrospun with tropoelastin in addition to gelatin and fibrinogen fibers were also fabricated and tested for the same amounts of GLUT vapor exposure. The current study details a computational method that was developed to predict the material properties of our constructs for crosslinking times between 2 and 24 hours by interpolation and regression of the 2, 8, and 24 hour crosslinking time data. Matlab and Abaqus were used to determine the optimal combination of fabrication parameters to produce compliance matched constructs. The validity of the method was first tested on a 16 hour crosslinked gelatin/fibrinogen construct of 130μm thickness. The predicted compliance was 0.00059 mmHg-1 while the experimentally determined compliance was 0.00065 mmHg-1, a relative difference of 9.2%. Prior data in our laboratory has shown the compliance of the left anterior descending porcine coronary (LADC) artery to be 0.00071 ± 0.0003 mmHg-1. The optimization algorithm predicts that a 258μm thick construct that is GLUT vapor crosslinked for 8.1 hours would match LADC compliance. The algorithm was expanded to predict the compliance of constructs consisting of alternating layers of tropoelastin/gelatin/fibrinogen and gelatin/fibrinogen. A four layered graft was designed and fabricated using this optimization routine. The layered construct was found to have a compliance of 0.00051 mmHg-1 while the predicted compliance was 0.00061 mmHg-1, a difference of 16%. This is a promising method for matching the compliance of our TEVGs with the native tissue of various specimens. graft optimization tissue-engineering compliance

Search results